Schizophrenia in later life

Aging Health

Volumn 3, Issue 3, 2007, Pages 383-396

  Vahia, Ipsit ^a   Bankole, Azziza O ^a   Reyes, Pia ^a   Diwan, Shilpa ^a   Palekar, Nikhil ^a   Sapra, Mamta ^a   Ramirez, Paul ^b   Cohen, Carl I ^a  

^a SUNY Downstate Medical Center   (United States)

^b LONG ISLAND UNIVERSITY   (United States)

Author keywords

Aging; Elderly; Late life; Psychosis; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

CAREGIVER BURDEN; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMMUNITY CARE; COMMUNITY LIVING; COMORBIDITY; COPING BEHAVIOR; DAILY LIFE ACTIVITY; DEMENTIA; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELDERLY CARE; ETHNIC DIFFERENCE; EXTRAPYRAMIDAL SYMPTOM; HEALTH CARE FINANCING; HUMAN; INCIDENCE; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; OUTPATIENT; PREDICTION; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA; SUICIDAL IDEATION; TARDIVE DYSKINESIA;

EID: 34250805908     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/1745509X.3.3.383     Document Type: Review

References (112)

1. McAlpine D: Patterns of care for persons 65 years and older with schizophrenia. In: Schizophrenia into Later Life. Carl M, Cohen I (Eds). American Psychiatric Publishing Inc., Washington DC, USA, 3-18 (2003).
2. Bartels SJ, Clark RE, Peacock WJ, Dums AR, Pratt SI: Medicare and medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients. Am. J. Geriatr. Psychiatry 11(6), 648-657 (2003).
3. Howard R, Rabins PV. Seeman MV, Jeste DV: Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am. J. Psychiatry 157(2), 172-178 (2000).
4. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV: Stability and course of neuropsychological deficits in schizophrenia. Arch. Gen. Psychiatry 58(1), 24-32 (2001).
5. Jeste D, Wetherell JL, Dolder CR: Schizophrenia and paranoid disorders. In: American Psychiatric Press Textbook of Geriatric Psychiatry. Blazer DG, Steffens DC, Busse E (Eds). American Psychiatric Publishing Inc., Washington DC, USA, 269-281 (2004).
6. Strauss JS, Carpenter WT Jr: The prediction of outcome in schizophrenia, II: relationship between predictor and outcome variables. Arch. Gen. Psychiatry 31, 37-42 (1974).
7. Harding CM: Changes in schizophrenia across time: paradoxes, patterns and predictors. In: Schizophrenia into Later Life. Carl M, Cohen I (Eds). American Psychiatric Publishing Inc. Vashington DC, USA, 19-42 (2003).
8. Harrison G, Hopper K, Craig T et al.: Recovery from Psychotic Illness: a 15- and 25-year international follow-up study. Br. J. Psychiatry 178, 506-517 (2001).
9. Modestin J, Huber A, Satirli E, Malti T, Hell D: Long-term course of schizophrenic illness: Bleuler's study reconsidered. Am. J. Psychiatry 160(12), 2202-2208 (2003).
10. Cohler BJ, Ferrono CL: Schizophrenia and the adult life course. In: Schizophrenia and Aging. Miller NE, Cohen GD (Eds). The Guilford Press, NY, USA, 189-199 (1987).
11. McGlashan TH, Fenton WS: The positive-negative distinction in schizophrenia. Review of natural history validators. Arch. Gen. Psychiatry 49(1), 63-72 (1992).
12. Schultz SK, Miller DD, Oliver SE, Arndt S, Flaum M, Andreasen NC: The life course of schizophrenia: age and symptom dimensions. Schizophr. Res. 23(1), 15-23 (1997).
13. Cohen CI, Talavera N, Hartung R: Depression among aging persons with schizophrenia who live in the community, Psychiatr. Serv. 47(6), 601-607 (1996).
14. Davidson M, Keefe RS: Cognitive impairment as a target for pharmacological treatment in schizophrenia. Schizophr. Res. 17(1), 123-129 (1995).
15. Liddle P, Carpenter WT, Crow T: Syndromes of schizophrenia. Classic literature. Br. J. Psychiatry 165(6), 721-727 (1994).
16. Lindenmayer JP, Negron AE, Shah S et al.: Cognitive deficits and psychopathology in elderly schizophrenic patients. Am. J. Geriatr. Psychiatry 5(1), 31-42 (1997).
17. Harvey PD, Lombardi J, Leibman M et al.: Verbal fluency deficits in geriatric and nongeriatric chronic schizophrenic patients. J. Neuropsychiatry Clin. Neurosci. 9(4), 584-590 (1997).
18. Ciompi L: The natural history of schizophrenia in the long term. Br. J. Psychiatry 136, 413-420 (1980).
19. Ciompi L: Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr. Bull. 6(4), 606-618 (1980).
20. Meeks S, Murrell SA: Mentall illness in late life: socioeconomic conditions, psychiatric symptoms, and adjustment of long-term sufferers. Psychol. Aging 12(2), 296-308 (1997).
21. Jeste DV, Twamley EW, Eyler Zorrilla LT, Golshan S, Patterson TL, Palmer BW: Aging and outcome in schizophrenia. Acta Psychiatr. Scand. 107(5), 336-343 (2003).
22. Siris SG: Depression in schizophrenia: perspective in the era of "atypical" antipsychotic agents. Am. J. Psychiatry 157(9), 1379-1389 (2000).
23. Baynes D, Mulholland C, Cooper SJ et al.: Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment. Schizophr. Res. 45(1-2), 47-56 (2000).
24. Lancon C, Auquier P, Reine G, Bernard D, Addington D: Relationships between depression and psychotic symptoms of schizophrenia during an acute episode and stable period. Schizophr. Res. 47(2-3), 135-140 (2001).
25. Krause N: Illness behavior in later life. In: Handbook of Aging and the Social Sciences. Binstock R, George L (Eds). Academic Press, CA, USA (1990).
26. Auslander LA, Lindamer LL, Delapena J et al.: A comparison of community-dwelling older schizophrenia patients by residential status. Acta Psychiatr. Scand. 103(5), 380-386 (2001).
27. Reyes P, Ramirez P, Cohen CI: Depression, psychosis and functioning in older adults with schizophrenia. Presented at: 58th Institute for Psychiatric Services. New York, NY, USA, 5-8 October 2006.
28. Diwan S, Ramirez P, Cohen CI: Diminishing depression in older adults with schizophrenia. Presented at: 58th Institute for Psychiatric Services. New York, NY, USA, 5-8 October 2006.
29. Montross L, Kasckow J, Golshan S, Solorzano E, Daly R, Zisook S: The continued need for suicide assessments among middle-aged and older patients with schizophrenia. Presented at: American Association for Geriatric Psychiatry 19th Annual Meeting. San Juan, Puerto Rico, 10-13 March 2006.
30. Siris SG, Addington D, Azorin JM, Falloon IR, Gerlach J, Hirsch SR: Depression in schizophrenia: recognition and management in the USA. Schizophr. Res. 47(2-3), 185-197 (2001).
31. Savla GN, Moore DJ, Roesch SC, Palmer BW, Jeste DV, Heaton R: An evaluation of longitudinal neurocognitive performance among middle aged and older schizophrenia patients: use of mixed model analyses. Schizophr. Res. 83, 215-223 (2006).
32. Cohen CI, Stastny P, Perlick D, Samuelly I, Horn L: Cognitive deficits among aging schizophrenic patients residing in the community. Hosp. Community Psychiatry 39(5), 557-559 (1988).
33. Harvey PD, Silverman JM, Mohs RC et al.: Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol. Psychiatry 45(1), 32-40 (1999).
34. Crum RM, Anthony JC, Bassett SS, Folstein MF: Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 269(18), 2386-2391 (1993).
35. Putnam KM, Harvey PD: Memory performance of geriatric and nongeriatric chronic schizophrenic patients: a cross-sectional study. J. Int. Neuropsychol. Soc. 5(6), 494-501 (1999).
36. Harvey PD, Howanitz E, Parrella M et al.: Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am. J. Psychiatry 155(8), 1080-1086 (1998).
37. Arnold SE, Gur RE, Shapiro RM et al.: Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients. Am. J. Psychiatry 152(5), 731-737 (1995).
38. Bartels SJ, Mueser KT, Miles KM: A comparative study of elderly patients with schizophrenia and bipolar disorder in nursing homes and the community. Schizophr. Res. 27(2-3), 181-190 (1997).
39. Friedman JI, Harvey PD, Coleman T et al.: Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am. J. Psychiatry 158(9), 1441-1448 (2001).
40. Vega U, Silberman C, Laks J, Braga RJ, Burdick KE: Association of education and cognitive status in Brazilian elderly institutionalized patients with schizophrenia. Schizophr. Res. 78(1), 107-109 (2005).
41. Davidson M, Harvey P, Welsh KA, Powchik P, Putnam KM, Mohs RC: Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease. Am. J. Psychiatry 153(10), 1274-1279 (1996).
42. Heaton R, Paulsen JS, McAdams LA et al.: Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. Arch. Gen. Psychiatry 51(6), 469-476 (1994).
43. Newman SC, Bland RC: Mortality in a cohort of patients with schizophrenia: a record linkage study. Can. J. Psychiatry 36(4), 239-245 (1991).
44. Factor SA, Brown D: Clozapine prevents recurrence of psychosis in Parkinson's disease. Mov. Disord. 7(2), 125-131 (1992).
45. Felker B, Yazel JJ, Short D: Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr. Serv. 47(12), 1356-1363 (1996).
46. Carney CP, Jones L, Woolson RF: Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J. Gen. Intern. Med. 21(11), 1133-1137 (2006).
47. Pary RJ, Barton SN: Communication difficulty of patients with schizophrenia and physical illness. South Med. J. 81(4), 489-490 (1988).
48. Druss BG, Rosenheck RA, Desai MM, Perlin JB: Quality of preventive medical care for patients with mental disorders. Med. Care 40(2), 129-136 (2002).
49. Auslander LA, Jeste DV: Perceptions of problems and needs for service among middle-aged and elderly outpatients with schizophrenia and related psychotic disorders. Community Ment. Health J. 38(5), 391-402 (2002).
50. Koranyl EK: Morbidity and rate of undiagnosed physical illnesses in a psychiatric clinic population. Arch. Gen. Psychiatry 36(4), 414-419 (1979).
51. Koran LM, Sox HC Jr, Marton KI et al.: Medical evaluation of psychiatric patients. I. Results in a state mental health system. Arch. Gen. Psychiatry 46(8), 733-740 (1989).
52. Vahia I, Diwan S, Bankole A, Cohen CI: Improving adequacy of medical care for older persons with schizophrenia. Presented at: 58th Institute for Psychiatric Services. New York, NY, USA, 5-8 October 2006.
53. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP: Medical comorbidity in schizophrenia. Schizophr. Bull. 22(3), 413-430 (1996).
54. Folsom DP, Lebowitz BD, Lindamer LA, Palmer BW, Patterson TL, Jeste DV: Schizophrenia in late life: emerging issues. Dialogues Clin. Neurosci. 8(1), 45-52 (2006).
55. Vahia I, Cohen CI: Improving adequacy of medical care for older persons with schizophrenia. Presented at: 58th Institute for Psychiatric Services. New York, NY, USA, 5-8 October 2006.
56. Jones S, Vahia I, Cohen CI: Comparing care provision by psychiatrists and primary care providers for older patients with schizophrenia. Presented at: American Association of Geriatric Psychiatry's 2007 Annual Meeting. New Orleans, LA, USA, 1-4 March 2007.
57. Bartels SJ, Forester B, Mueser KT et al.: Enhanced skills training and health care management for older persons with severe mental illness. Community Ment. Health J. 40(1), 75-90 (2004).
58. Eastham J, Patterson TL, Rockwell E et al.: Movement disorders and functional impairment in middle-aged and elderly schizophrenia patients. Presented at: The Annual Meeting of the American Psychiatric Association. San Diego, CA, USA, 17-22 May 1997.
59. Klapow JC, Evans J, Patterson TL, Heaton RK, Koch WL, Jeste DV: Direct assessment of functional status in older patients with schizophrenia. Am. J. Psychiatry 154(7), 1022-1024 (1997).
60. Patterson TL, Klapow JC, Eastham JH et al.: Correlates of functional status in older patients with schizophrenia. Psychiatry Res. 80(1), 41-52 (1998).
61. Bartels SJ, Mueser K, Miles KM: Functional impairments in elderly patients with schlzohprenia and and major affective illness in the community: social skills, living skills, and behavior problems Behav. Ther. 28, 43-63 (1997).
62. Palmer BW, Heaton RK, Gladsjo JA et al.: Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving. Schizophr. Res. 55(3), 205-215 (2002).
63. Bowie CR, Twamley EW, Anderson H, Halpern B, Patterson TL, Harvey PD: Self-assessment of functional status in schlzophrenia. J. Psychiatr. Res. (2006) (Epub ahead of print).
64. Gupta S, Steinmeyer C, Frank B, Lockwood K, Lentz B, Schultz K: Older patients with schizophrenia: nature of dwelling status and symptom severity. Am. J. Psychiatry 160(2), 383-384 (2003).
65. Evans JD, Heaton RK, Paulsen JS, Palmer BW, Patterson T, Jeste DV: The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients. Biol. Psychiatry 53(5), 422-430 (2003).
66. Cohen CI, Talavera N: Functional impairment in older schizophrenic persons. Toward a conceptual model. Am. J. Geriatr. Psychiatry 8(3), 237-244 (2000).
67. Meeks S, Walker J: Blunted affect, blunted lives? Negative symptoms, ADL functioning, and mental health among older adults. Int. J. Geriatr. Psychiatry 5, 233-238 (1990).
68. Gill TM, Feinstein AR: A critical appraisal of the quality of quality-of-life measurements. JAMA 272(8), 619-626 (1994).
69. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol. Med. 28(3), 551-558 (1998).
70. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30(6), 473-483 (1992).
71. Anderson JP, Kaplan RM, Berry CC, Bush JW, Rumbaut RG: Interday reliability of function assessment for a health status measure. The Quality of Well-Being scale. Med. Care 27(11), 1076-1083 (1989).
72. Cohen CI, Ramirez PM, Kehn M, Magai C, Eimicke J, Brenner R: Assessing quality of life in older persons with schizophrenia. Am. J. Geriatr. Psychiatry 11(6), 658-666 (2003).
73. Jin H, Zisook S, Palmer BW, Patterson TL, Heaton RK, Jeste DV: Association of depressive symptoms with worse functioning in schizophrenia: a study in older outpatient. J. Clin. Psychiatry 62(10), 797-803 (2001).
74. Sciolla A, Patterson TL, Wetherell JL, McAdams LA, Jeste DV: Functioning and well-being of middle-aged and older patients with schizophrenia: measurement with the 36-item short-form (SF-36) health survey. Am. J. Geriatr. Psychiatry 11 (6), 629-637 (2003).
75. Bankole A, Vahia I, Diwan S, Palekar N, Ramirez P, Cohen CI: Enhancing quality of life in the elderly with schizophrenia. Presented at: 58th Institute for Psychiatric Services. New York, NY, USA, 5-8 October 2006.
76. Borge L, Martinsen EW, Ruud T, Watne O, Frits S: Quality of life, loneliness, and social contact among long terat psychiatric patients. Psychiatr. Serv. 50 (1), 81-84 (1999).
77. Granholm E, McQuaid JR, McClure FS et al.: A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. Am. J. Psychiatry 162(3), 520-529 (2005).
78. Karow, A, Naber D: Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology (Berl.) 162(1), 3-10 (2002).
79. Law CW, Chen EY, Cheung EF et al.: Impact of untreated psychosis on quality of life in patients with first-episode schizophresnia. Qual. Life Res. 14(8), 1803-1811 (2005).
80. Mechanic D, McAlpine D, Rosenfield S, Davis D: Effects of illness attribution and depression on the quality of life among persons with serious mental illness. Soc. Sci. Med. 39(2), 155-164 (1994).
81. Wegener S, Redoblado-Hodge MA, Lucas S, Fitzgerald D, Harris A, Brennan J: Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust. NZ J. Psychiatry 39(6), 487-492 (2005).
82. Fitzgerald PB, de Castella AR, Filla K et al.: A longitudinal study of patient- and observer-rated quality of life in schizophrenia. Psychiatry Res. 119(1-2), 55-62 (2003).
83. Sands JR, Harrow M: Depression during the longitudinal course of schisophrenia. Schizophr. Bull. 25(1), 157-171 (1999).
84. Cardoso CS, Caiaffa WT, Bandeira M, Siqueira AL, Abreu MN, Fonseca JO: Factors associated with low quality of life in schizophrenia. Cad. Saude Publica, 21(5), 1338-1340 (2005).
85. Caron J, Lecomte Y, Stip E, Renaud S: Predictors of quality of life in schizophrenia. Community Ment. Health J. 41(4), 399-417 (2005).
86. Sample SJ, Patterson TL, Shaw WS et al.: The social networks of older schizophrenia patients. Clinical Research Center on Late Life Psychosis Research Group. Int. Psychogeriatr. 9(1), 81-94 (1997).
87. Cohen CI, Vahia I, Diwan S, Bankole A, Palekar N, Ramirez P: Adaptive functioning in older persons with schizophrenia. Presented at: 2006 Annual Meeting of the American Psychiatric Association. Toronto, ON, Canada, 20-25 May 2006.
88. Lefley HP: Changing caregiving needs as persons with schizophrenia grow older. In: Schizophrenia into Later Life. Carl M, Cohen I (Eds). American Psychiatric Publishing Inc., Washington DC, USA, 251-269 (2003).
89. Stueve A, Vine P, Struening E: Perceived burden among caregivers of adults with serious mental illnes: comparison of black, Hispanic and white families. Am. J. Orthopsychiatry 67(2), 199-209 (1997).
90. Jeste DV, Rockwell E, Harris MJ, Lohr JB, Lacro J: Conventional vs. newer antipsychotics in elderly patients. Am J. Geriatr. Psychiatry 7(1), 70-76 (1999).
91. Alexopoulos GS, Streim J, Carpenter D, Docherty JP: Using antipsychotic agents in older patients. J. Clin. Psychiatry 65(Suppl. 2), 5-99; discussion 100-102; quiz 103-104 (2004).
92. Lieberman JA, Stroup TS, McEvoy JP et al.: Effectivenes of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353(12), 1209-1223 (2005).
93. Masand PS, Gupta S: Long-acting injectable antipsychotics in the elderly: guidelines for effective use. Drugs Aging 20(15), 1099-1110 (2003).
94. Heinssen RK, Liberman RP, Kopelowicz A: Psychosocial skills training for schizophrenia: lessons from the laboratory. Schizophr. Bull. 26(1), 21-46 (2000).
95. Wilkins S, Osato S, Kern RS: Educational groups to increase medication adherence in geriatric patients. Presented at: 50th Annual Meeting of the Gerontological Society of America, Los Angeles, CA, USA, 15-19 November 1995.
96. Kopelowicz A, Liberman RP: Integrating treatment with rehabilitation for persons with major mental illnesses. Psychiatr. Serv. 54(11), 1491-1498 (2003).
97. Kopelowicz A, Liberman RP, Zarate R: Recent advances in social skills training for schizophrenia. Schizophr. Bull. 32(Suppl. 1), S12-S23 (2006).
98. Twamley EW, Padin DS, Bayne KS, Jeste D: Work rehabilitation for middle aged and older people with schizophrenia: a comparison of three approaches. J. Nerv. Ment. Dis. 193, 596-601 (2005).
99. Chengappa KN, Baker RW, Kreinbrook SB, Adair D: Clozapine use in female geriatric patients with psychoses. J. Geriatr. Psychiatry Neurol. 8(1), 12-15 (1995).
100. Mohamed S, Kasckow J, Granholm E, Jeste D: Community-based treatment of schizophrenia and other severe mental illnesses. In: Schizophrenia into Later Life. Carl M, Cohen I (Eds). American Psychiatric Publishing Inc., Washington DC, USA, 205-222 (2003).
101. Cohen CI: Community care. In: Comprehensive Textbook of Geriatric Psychiatry. Grossberg T (Ed.) WW Norton and Company, NY, USA (2004).
102. Mittal D, Davis CE, Depp, C et al.: Correlates of health-related quality of well-being in older patients with schizophrenia. J. Nerv. Ment. Dis. 194(5), 335-340 (2006).
103. Jeste DV, Lacro JP, Balley A, Rockwell E, Harris MJ, Caligiuri MP: Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J. Am. Geriatr. Soc. 47(6), 716-719 (1999).
104. Madhusoodanan S, Brecher M, Brenner R et al.: Risperidone in the treatment of elderly patients with psychotic disorders. Am. J. Geriatr. Psychiatry 7(2), 132-138 (1999).
105. Feldman PD, Kaiser CJ, Kennedy JS et al.: Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years. J. Clin. Psychiatry 64(9), 998-1004 (2003).
106. Jeste DV, Barak Y, Madhusoodanan S, Grossman F, Gharabawi G: International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia. Am. J. Geriatr. Psychiatry 11(6), 638-647 (2003).
107. Madhusoodanan S, Brenner R, Suresh P. et al.: Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study. Ann. Clin Psychiatry 12(1), 11-18 (2000).
108. Sajatrovic M, Madhusoodanan S, Fuller MA, Aulakh L, Keaton DB: Risperidone for bipolar disorders. Expert Rev. Neurother. 5(2), 177-187 (2005).
109. Arvantis LA, Rak IW: Efficacy, safety and tolerability of 'Seroquel' (quetiapine) in elderly subjects with psychotic disorders. Schizophr. Res. 24, 196 (1997).
110. Madhusoodanan S, Brenner R, Alcantra A: Clinical experience with quetiapine in elderly patients with psychotic disorders. J. Geriatr. Psychiatry Neurol. 13(1), 28-32 (2000).
111. Barak Y, Mazeh D, Plopski I, Baruch Y: Irtramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia. Am. J. Geriatr. Psychiatry 14(7), 629-633 (2006).
112. Madhusoodanan S, Brenner R, Gupta S, Reddy H, Bogunovic O: Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studies. CNS Spectr. 9(11), 862-867 (2004).